Iambic Therapeutics Inc.
Last updated October 17, 2026
Organization details
- Legal name
- Iambic Therapeutics Inc.
- Ownership
- Public
- Status
- Active
- Headquarters country
- United States
- Ticker symbol
- IAM
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001997038
Board of directors
-
Evan Lockwood Rachlin · DirectorSince 2026
-
Frederick R. Manby · Director · Chief Technology OfficerSince 2026
-
Kurt Von Emster · DirectorSince 2026
-
Mary Tagliaferri · DirectorSince 2026
-
R. Jacob Vogelstein · DirectorSince 2026
- Since 2026
-
Thomas F. Miller · Director · Chief Executive OfficerSince 2026
-
William H. Rastetter · DirectorSince 2026
Chief executives
Thomas F. Miller
· Chief Executive Officer
Dates unknown
Board connections
5 of this board's directors also sit on 9 other boards.
- via Shalini Sharp and William H. Rastetter
- via Mary Tagliaferri
- via Shalini Sharp
- via William H. Rastetter
- via William H. Rastetter
- via Kurt Von Emster
- via Shalini Sharp
- via Shalini Sharp
- via Thomas F. Miller
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $0
- 0 purchases by 0 insiders
- Sold, last 12 months
- $0
- 0 sales by 0 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Oct 14, 2026 | Secora Michael Officer (CFO & Chief Corp Dev Ofcr) | Grant or award | +28,400 | — | — |
| Oct 14, 2026 | Josephson Neil Officer (Chief Medical Officer) | Grant or award | +31,000 | — | — |
| Oct 14, 2026 | Thomas F. Miller Director, Officer (Chief Executive Officer) | Grant or award | +132,200 | — | — |
| Oct 14, 2026 | Olson Peter A Officer (Chief Scientific Officer) | Grant or award | +19,500 | — | — |
| Oct 14, 2026 | Frederick R. Manby Director, Officer (Chief Technology Officer) | Grant or award | +132,200 | — | — |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.